Medica Sur SA de CV

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: MXP510121215
MXN
62.00
17 (37.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,179.97
1,181.30
1,204.93
1,131.78
1,117.44
1,073.86
1,079.74
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,179.97
1,181.30
1,204.93
1,131.78
1,117.44
1,073.86
1,079.74
Raw Material Cost
769.16
746.83
774.35
750.82
745.48
717.82
697.09
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
41.02
19.10
18.88
18.93
18.96
19.11
18.57
Selling and Distribution Expenses
230.02
237.60
228.53
201.50
230.56
215.08
209.95
Other Expenses
-4.10
-1.91
-1.89
-1.89
-1.90
-1.91
-1.86
Total Expenditure (Excl Depreciation)
999.18
984.44
1,002.87
952.32
976.04
932.90
907.04
Operating Profit (PBDIT) excl Other Income
180.79999999999998
196.9
202.10000000000002
179.5
141.4
141
172.7
Other Income
41.54
19.62
25.40
29.34
47.25
-61.03
19.64
Operating Profit (PBDIT)
270.45
267.50
277.70
259.26
239.62
126.80
238.21
Interest
41.02
19.10
18.88
18.93
18.96
19.11
18.57
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
410.81
434.47
430.59
380.96
371.95
356.04
382.66
Depreciation
48.12
51.01
50.24
50.46
50.97
46.88
45.87
Profit Before Tax
181.31
197.39
208.58
189.88
169.69
60.82
173.78
Tax
57.78
61.53
66.23
54.91
47.50
17.41
51.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
123.53
135.85
142.35
134.97
122.19
43.41
121.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
123.53
135.85
142.35
134.97
122.19
43.41
121.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
123.53
135.85
142.35
134.97
122.19
43.41
121.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,561.53
2,465.60
2,485.39
2,343.04
2,221.49
2,099.30
2,158.15
Earnings per share (EPS)
1.56
1.7
1.78
1.69
1.52
0.54
1.52
Diluted Earnings per share
1.56
1.7
1.78
1.69
1.52
0.54
1.52
Operating Profit Margin (Excl OI)
15.32%
16.67%
16.77%
15.86%
12.65%
13.13%
15.99%
Gross Profit Margin
19.44%
21.03%
21.48%
21.23%
19.75%
10.03%
20.34%
PAT Margin
10.47%
11.5%
11.81%
11.93%
10.93%
4.04%
11.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -0.11% vs -1.96% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -9.12% vs -4.50% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -7.66% vs -1.74% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 114.66% vs 1.06% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Medica Sur SA de CV With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(MXN)
Change(%)
Net Sales
1,179.97
0
1,179.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,179.97
0
1,179.97
Raw Material Cost
769.16
0
769.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
41.02
0
41.02
Selling and Distribution Expenses
230.02
0
230.02
Other Expenses
-4.10
0.00
-4.10
Total Expenditure (Excl Depreciation)
999.18
0
999.18
Operating Profit (PBDIT) excl Other Income
180.79
0.00
180.79
Other Income
41.54
0
41.54
Operating Profit (PBDIT)
270.45
0
270.45
Interest
41.02
0
41.02
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
410.81
0
410.81
Depreciation
48.12
0
48.12
Profit Before Tax
181.31
0
181.31
Tax
57.78
0
57.78
Provisions and contingencies
0
0
0.00
Profit After Tax
123.53
0
123.53
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
123.53
0
123.53
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
123.53
0
123.53
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
2,561.53
0
2,561.53
Earnings per share (EPS)
1.56
0
1.56
Diluted Earnings per share
1.56
0
1.56
Operating Profit Margin (Excl OI)
15.32%
0%
0.00
15.32%
Gross Profit Margin
19.44%
0%
0.00
19.44%
PAT Margin
10.47%
0%
0.00
10.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 118.00 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -0.11% vs -1.96% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 5.60% vs 16.82% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 12.35 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -9.12% vs -4.50% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 1.06% vs -39.11% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.89 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -7.66% vs -1.74% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 18.97% vs 11.73% in Sep 2024

Quarterly - Interest
Interest 4.10 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 114.66% vs 1.06% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 115.79% vs 4.40% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.32%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024